icd-9-cm code for bronhomalacia

What is the ICD 10 code for congenital bronchomalacia?

Congenital bronchomalacia 2016 2017 2018 2019 2020 2021 Billable/Specific Code POA Exempt Q32.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM Q32.2 became effective on October 1, 2020.

What is the ICD 9 code for laryngotrach anomaly?

Short description: Laryngotrach anomaly NEC. ICD-9-CM 748.3 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 748.3 should only be used for claims with a date of service on or before September 30, 2015.

What is the ICD 9 code for diagnosis?

ICD-9-CM 519.19 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 519.19 should only be used for claims with a date of service on or before September 30, 2015.

What is the ICD 10 code for atresia with segmental pulmonary emphysema?

748.3 is a legacy non-billable code used to specify a medical diagnosis of other anomalies of larynx, trachea, and bronchus. This code was replaced on September 30, 2015 by its ICD-10 equivalent. Bronchial atresia with segmental pulmonary emphysema Congenital cleft of posterior cricoid cartilage Congenital malformation of trachea and bronchus

What is ICD 10 Tracheomalacia?

Q32. 0 - Congenital tracheomalacia | ICD-10-CM.

What is the ICD 9 code for malnutrition?

Table 5ICD-9-CM diagnosis codes for malnutritionICD-9-CM diagnosis codeDescriptionPostsurgical nonabsorptionProtein-calorie malnutrition260Kwashiorkor261Nutritional marasmus21 more rows

What is the ICD-10-CM code for malnutrition?

E40-E46 - Malnutrition | ICD-10-CM.

How do you code malnutrition?

Coding professionals would use ICD-10-CM code E43 to report severe malnutrition, also known as starvation edema. They would use ICD-10-CM code E42 to report severe protein-calorie malnutrition with signs of both kwashiorkor and marasmus.

What is the ICd 10 code for bronchitis?

748.3 is a legacy non-billable code used to specify a medical diagnosis of other anomalies of larynx, trachea, and bronchus. This code was replaced on September 30, 2015 by its ICD-10 equivalent.

What is the ICd-9 GEM?

The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

Abstract

Bronchiolitis is a common respiratory disorder in children. Although there are specific ICD-9-CM diagnosis codes for bronchiolitis, the illness is often coded using broader diagnosis codes. This creates the potential for subject misclassification if researchers rely on specific diagnosis codes when assembling retrospective cohorts.

Background

Bronchiolitis is one of the most common causes of morbidity in pediatrics [ 1 ]. Bronchiolitis is characterized by symptoms of lower airway obstruction, typically characterized by wheezing, chest wall retractions, and later crackles, following a period of coughing and rhinorrhea [ 2 ].

Methods

The State of California Committee for Protection of Human Subjects and the State of California and DHCS approved this study. Data was obtained from the California Medic-Aid Management Information System/Decision Support System (MMIS/DSS).

Results

We identified visits from 48,732 children for first episode of wheezing illness. We retained 48,269 who had the diagnosis codes of interest. Broad criteria (e.g. asthma, bronchospasm) were widely used, even when based on the age less than six months and first episode of wheezing a narrow diagnostic code would have been anticipated.

Discussion

We found that most children who probably had bronchiolitis were instead assigned other ICD-9-CM codes likely reflecting extensive diagnosis misclassification.

Conclusions

Users of administrative data should generally favor age-limited broad rather than narrow definitions of bronchiolitis and should perform sensitivity analysis comparing broad and narrow definitions prior to relying only on narrow definitions.

Acknowledgments

The authors acknowledge Bradley Chipps, MD for his comments on the graphical analyses, and John Igwe MPA, and Donnie Minor, PharmD at the California Department of Health Care Services.